MENU
+Compare
BFRI
Stock ticker: NASDAQ
AS OF
May 9 closing price
Price
$0.69
Change
-$0.04 (-5.48%)
Capitalization
9.77M

BFRI Biofrontera Forecast, Technical & Fundamental Analysis

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy... Show more

BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BFRI with price predictions
May 09, 2025

BFRI in -5.45% downward trend, sliding for three consecutive days on May 01, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BFRI declined for three days, in of 246 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BFRI as a result. In of 59 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BFRI turned negative on April 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 29 similar instances when the indicator turned negative. In of the 29 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for BFRI entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BFRI's RSI Indicator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BFRI advanced for three days, in of 151 cases, the price rose further within the following month. The odds of a continued upward trend are .

BFRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.039) is normal, around the industry mean (60.926). P/E Ratio (0.000) is within average values for comparable stocks, (88.912). BFRI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.087) is also within normal values, averaging (19.413).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BFRI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BFRI is expected to report earnings to rise 22.22% to -21 cents per share on August 11

Biofrontera BFRI Stock Earnings Reports
Q2'23
Est.
$-0.22
Q4'24
Beat
by $0.02
Q1'23
Missed
by $0.20
Q4'22
Missed
by $0.04
Q3'22
Beat
by $0.18
The last earnings report on March 20 showed earnings per share of -18 cents, beating the estimate of -20 cents. With 61.37K shares outstanding, the current market capitalization sits at 9.77M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
120 Presidential Way
Phone
+1 781 245-1325
Employees
85
Web
https://www.biofrontera-us.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DURAX13.61N/A
N/A
DWS ESG International Core Eq A
RPMFX15.04N/A
N/A
Reinhart Genesis PMV Advisor
MSIWX15.40N/A
N/A
Morgan Stanley Inst EMkts Ldrs IR
FGINX14.78-0.04
-0.27%
Macquarie Growth and Income A
WSTCX22.00-0.10
-0.45%
Macquarie Science and Technology C

BFRI and Stocks

Correlation & Price change

A.I.dvisor tells us that BFRI and ACET have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
-4.47%
ACET - BFRI
25%
Poorly correlated
+27.49%
DVAX - BFRI
23%
Poorly correlated
-2.89%
HCM - BFRI
23%
Poorly correlated
-2.27%
LNTH - BFRI
23%
Poorly correlated
+1.62%
EVO - BFRI
23%
Poorly correlated
+9.97%
More